Researchers have been excited about the medication , a novel dual treatment showing remarkable results in early trials for body loss . It acts by targeting several pathways : GLP-1 and GIP, these, when https://abelcncg727467.ambien-blog.com/47620125/this-new-hope-for-body-loss